Are you Dr. Riedlinger?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 17 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
Rutgers Cancer Institute of New Jersey
195 Little Albany Parkway Room 3553
New Brunswick, NJ 08903Phone+1 732-235-8978
Summary
- Dr. Gregory Riedlinger, MD is a board certified pathologist in New Brunswick, New Jersey. He is currently licensed to practice medicine in New Jersey, Massachusetts, and Maryland. He is affiliated with Robert Wood Johnson University Hospital.
Education & Training
- National Institutes of Health Clinical CenterResidency, Pathology-Anatomic and Clinical, 2010 - 2013
- Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 2009
Certifications & Licensure
- NJ State Medical License 2015 - 2025
- PA State Medical License 2013 - 2016
- MA State Medical License 2013 - 2014
- MD State Medical License 2013 - 2013
- American Board of Pathology Pathology - Anatomic
- American Board of Pathology Pathology - Molecular Genetic
Publications & Presentations
PubMed
- 4 citationsComprehensive genomic profiling aids in treatment of a metastatic endometrial cancer.Jatinder Dhami, Kim M. Hirshfield, Shridar Ganesan, Mira Hellmann, Veronica Rojas
Cold Spring Harbor Molecular Case Studies. 2018-04-01 - 4 citationsSmoking-associated Downregulation of FILIP1L Enhances Lung Adenocarcinoma Progression Through Mucin Production, Inflammation, and Fibrosis.Mijung Kwon, Genesaret Rubio, Haitao Wang, Gregory Riedlinger, Asha Adem
Cancer Research Communications. 2022-10-01 - 28 citationsCancer risk and clinicopathological characteristics of thyroid nodules harboring thyroid-stimulating hormone receptor gene mutations.Sann Y. Mon, Gregory Riedlinger, Collette E. Abbott, Raja R. Seethala, N. Paul Ohori
Diagnostic Cytopathology. 2018-05-01
Press Mentions
- Solid Tumor Genomic Sequencing Can Reveal Coexistent Hematologic MalignancyJanuary 2nd, 2019
- CHIPing Away at Cancer Tumors Through Genomic AnalysisApril 23rd, 2018